NSAIDs Modulate Clonal Evolution in Barrett's Esophagus

Cancer is considered an outcome of decades-long clonal evolution fueled by acquisition of somatic genomic abnormalities (SGAs). Non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to reduce cancer risk, including risk of progression from Barrett's esophagus (BE) to esophageal adenoca...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Kostadinov, Rumen L., Kuhner, Mary K., Li, Xiaohong, Sanchez, Carissa A., Galipeau, Patricia C., Paulson, Thomas G., Sather, Cassandra L., Srivastava, Amitabh, Odze, Robert D., Blount, Patricia L., Vaughan, Thomas L., Reid, Brian J., Maley, Carlo C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2013
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3681672/
https://ncbi.nlm.nih.gov/pubmed/23785299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pgen.1003553
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller